US demand for anti-aging products will rise 8.7 percent annually through 2009. Memory improvement, vision care and prostate care products will lead gains. Chemicals expected to benefit include memory-enhancing neurological and ophthalmic agents, botulinum toxin for wrinkle reduction, and herbal extracts such as lutein, lycopene and black cohosh.
This study analyzes the $20 billion US anti-aging product industry. It presents historical demand data for 1994, 1999 and 2004 and forecasts to 2009 and 2014 by product (e.g., bone and joint care, sexual dysfunction/impotence, menopause, prostate care, vision care, memory improvement, aging skin care, hair loss); and by chemical (e.g., active ingredients, vitamins and antioxidants, chondroitin, hormones, herbal extracts, glucosamine, minerals, proteins, botulinum toxin).
The study also considers market environment trends and indicators, evaluates company market share and profiles 38 leading competitors including Pfizer, Merck & Company, Wyeth, BASF, and Eli Lilly.
